(Q36231663)

12 August 2017

1 reference

title

Pharmacotherapy review: angiotensin-converting enzyme inhibitors (English)

1 reference

12 August 2017

0 references

Domenic A Sica

1

1 reference

12 August 2017

publication date

1 August 2005

1 reference

Journal of Clinical Hypertension

12 August 2017

published in

1 reference

12 August 2017

volume

7

1 reference

12 August 2017

issue

8

1 reference

12 August 2017

page(s)

485-488

1 reference

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Pharmacogenomics of blood pressure response to antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

A double-blind, placebo-controlled, dose–response study of the effectiveness and safety of lisinopril for children with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

American College of Sports Medicine position stand. Exercise and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Blood pressure response to conventional and low-dose enalapril in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Treatment of hypertensive patients with coexisting coronary arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Calcium channel blocker-related periperal edema: can it be resolved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy: its role in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

Dosage considerations with perindopril for systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2005.04125.X

10.1111/J.1524-6175.2005.04125.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference